TABLE OF CONTENTS
EXECUTIVE SUMMARY 2
MARKET OVERVIEW 7
Market definition 7
Research highlights 8
Market analysis 9
MARKET VALUE 10
MARKET SEGMENTATION I 11
MARKET SHARE 12
FIVE FORCES ANALYSIS 13
Summary 13
Buyer power 15
Supplier power 16
New entrants 17
Substitutes 19
Rivalry 20
LEADING COMPANIES 21
Pharma Natura (Pty) Ltd 21
Weleda Group 22
Johnson & Johnson 23
MARKET DISTRIBUTION 28
MARKET FORECASTS 29
Market value forecast 29
MACROECONOMIC INDICATORS 30
APPENDIX 32
Methodology 32
Industry associations 33
Related Datamonitor research 33
Disclaimer 35
ABOUT DATAMONITOR 36
Premium Reports 36
Summary Reports 36
Datamonitor consulting 36
LIST OF TABLES
Table 1: South Africa OTC pharmaceuticals market value: $ million, 2005–09 10
Table 2: South Africa OTC pharmaceuticals market segmentation I:% share, by value, 2009 11
Table 3: South Africa OTC pharmaceuticals market share: % share, by value, 2009 12
Table 4: Pharma Natura (Pty) Ltd: key facts 21
Table 5: Weleda Group: key facts 22
Table 6: Johnson & Johnson: key facts 23
Table 7: Johnson & Johnson: key financials ($) 25
Table 8: Johnson & Johnson: key financial ratios 26
Table 9: South Africa OTC pharmaceuticals market distribution: % share, by value, 2009 28
Table 10: South Africa OTC pharmaceuticals market value forecast: $ million, 2009–14 29
Table 11: South Africa size of population (million), 2005–09 30
Table 12: South Africa gdp (constant 2000 prices, $ billion), 2005–09 30
Table 13: South Africa gdp (current prices, $ billion), 2005–09 30
Table 14: South Africa inflation, 2005–09 31
Table 15: South Africa consumer price index (absolute), 2005–09 31
Table 16: South Africa exchange rate, 2005–09 31
LIST OF FIGURES
Figure 1: South Africa OTC pharmaceuticals market value: $ million, 2005–09 10
Figure 2: South Africa OTC pharmaceuticals market segmentation I:% share, by value, 2009 11
Figure 3: South Africa OTC pharmaceuticals market share: % share, by value, 2009 12
Figure 4: Forces driving competition in the OTC pharmaceuticals market in South Africa, 2009 13
Figure 5: Drivers of buyer power in the OTC pharmaceuticals market in South Africa, 2009 15
Figure 6: Drivers of supplier power in the OTC pharmaceuticals market in South Africa, 2009 16
Figure 7: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in South Africa, 2009 17
Figure 8: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in South Africa, 2009 19
Figure 9: Drivers of degree of rivalry in the OTC pharmaceuticals market in South Africa, 2009 20
Figure 10: Johnson & Johnson: revenues & profitability 26
Figure 11: Johnson & Johnson: assets & liabilities 27
Figure 12: South Africa OTC pharmaceuticals market distribution: % share, by value, 2009 28
Figure 13: South Africa OTC pharmaceuticals market value forecast: $ million, 2009–14 29
[Fade out table of contents]
